Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC474714464;14465;14466 chr2:178738214;178738213;178738212chr2:179602941;179602940;179602939
N2AB443013513;13514;13515 chr2:178738214;178738213;178738212chr2:179602941;179602940;179602939
N2A350310732;10733;10734 chr2:178738214;178738213;178738212chr2:179602941;179602940;179602939
N2B438413375;13376;13377 chr2:178738214;178738213;178738212chr2:179602941;179602940;179602939
Novex-1450913750;13751;13752 chr2:178738214;178738213;178738212chr2:179602941;179602940;179602939
Novex-2457613951;13952;13953 chr2:178738214;178738213;178738212chr2:179602941;179602940;179602939
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCT
  • RefSeq wild type template codon: AGA
  • Domain: Ig-30
  • Domain position: 48
  • Structural Position: 122
  • Q(SASA): 0.2842
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/C rs1363033770 -0.654 0.997 N 0.4 0.359 0.42989457901 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 5.61E-05 None 0 None 0 0 0
S/C rs1363033770 -0.654 0.997 N 0.4 0.359 0.42989457901 gnomAD-4.0.0 1.59156E-06 None None None None N None 0 0 None 0 2.77932E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.1015 likely_benign 0.1204 benign -0.857 Destabilizing 0.022 N 0.116 neutral N 0.443383317 None None N
S/C 0.1826 likely_benign 0.217 benign -0.829 Destabilizing 0.997 D 0.4 neutral N 0.444797087 None None N
S/D 0.6437 likely_pathogenic 0.7008 pathogenic -0.896 Destabilizing 0.842 D 0.298 neutral None None None None N
S/E 0.74 likely_pathogenic 0.7667 pathogenic -0.868 Destabilizing 0.688 D 0.32 neutral None None None None N
S/F 0.2256 likely_benign 0.3019 benign -1.041 Destabilizing 0.966 D 0.461 neutral N 0.44464574 None None N
S/G 0.1807 likely_benign 0.228 benign -1.107 Destabilizing 0.688 D 0.302 neutral None None None None N
S/H 0.4496 ambiguous 0.4549 ambiguous -1.525 Destabilizing 0.991 D 0.409 neutral None None None None N
S/I 0.2004 likely_benign 0.2515 benign -0.286 Destabilizing 0.949 D 0.433 neutral None None None None N
S/K 0.8309 likely_pathogenic 0.8364 pathogenic -0.705 Destabilizing 0.067 N 0.108 neutral None None None None N
S/L 0.1129 likely_benign 0.1392 benign -0.286 Destabilizing 0.728 D 0.403 neutral None None None None N
S/M 0.2618 likely_benign 0.3094 benign -0.026 Destabilizing 0.991 D 0.409 neutral None None None None N
S/N 0.1981 likely_benign 0.2571 benign -0.836 Destabilizing 0.842 D 0.336 neutral None None None None N
S/P 0.9013 likely_pathogenic 0.9301 pathogenic -0.444 Destabilizing 0.891 D 0.401 neutral N 0.444432979 None None N
S/Q 0.655 likely_pathogenic 0.6574 pathogenic -1.04 Destabilizing 0.842 D 0.353 neutral None None None None N
S/R 0.7198 likely_pathogenic 0.7339 pathogenic -0.588 Destabilizing 0.007 N 0.161 neutral None None None None N
S/T 0.0986 likely_benign 0.1149 benign -0.803 Destabilizing 0.051 N 0.121 neutral N 0.443703351 None None N
S/V 0.2071 likely_benign 0.2556 benign -0.444 Destabilizing 0.728 D 0.403 neutral None None None None N
S/W 0.4551 ambiguous 0.5196 ambiguous -1.01 Destabilizing 0.998 D 0.521 neutral None None None None N
S/Y 0.2287 likely_benign 0.2917 benign -0.713 Destabilizing 0.989 D 0.463 neutral N 0.44464574 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.